Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volume replacement therapy in cardiac surgery: effect on renal function
2011-003173-28Phase 4Terminated
- Sponsor
- Helsinki University Hospital
- Start
- Mar 2012
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of Volulyte, ringer's acetate in cardiac morbidity, sponsored by Helsinki University Hospital. Started Mar 2012; status: terminated.
02
Drugs
Volulyteringer's acetate
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on 2011-003173-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003173-28.